Targeted treatments for cirrhosis (Q35911123)

11 August 2017

1 reference

title

Targeted treatments for cirrhosis (English)

1 reference

11 August 2017

Jonathan A Fallowfield

series ordinal

1

1 reference

PubMed ID

15469393

11 August 2017

John P Iredale

series ordinal

2

1 reference

PubMed ID

15469393

11 August 2017

language of work or name

English

0 references

publication date

1 October 2004

1 reference

Expert Opinion on Therapeutic Targets

11 August 2017

1 reference

11 August 2017

8

1 reference

11 August 2017

423-435

1 reference

11 August 2017

5

1 reference

Hepatic blood flow regulation by stellate cells in normal and injured liver

11 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Cytokine receptors and signaling in hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Changes in melatonin concentrations during IFN therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Apoptosis of human hepatic myofibroblasts promotes activation of matrix metalloproteinase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Collagen breakdown in soft connective tissue explants is associated with the level of active gelatinase A (MMP-2) but not with collagenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

JunD regulates transcription of the tissue inhibitor of metalloproteinases-1 and interleukin-6 genes in activated hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Inhibition of integrin signaling with Arg-Gly-Asp motifs in rat hepatic stellate cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Integrin alpha v beta 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Prognosis of Wilsonian chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Use of corticosteroid therapy in autoimmune hepatitis resulting in the resolution of cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Transfer of the interleukin-1 receptor antagonist gene into rat liver abrogates hepatic ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Adenovirus-mediated gene transfer of interferon alpha inhibits hepatitis C virus replication in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

A pilot study of the effects of d-alpha-tocopherol on hepatic stellate cell activation in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Protective effect of polyunsaturated phosphatidylcholine on liver damage induced by biliary obstruction in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Hepatocyte growth factor gene therapy of liver cirrhosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Hepatoprotective effects of 18beta-glycyrrhetinic acid on carbon tetrachloride-induced liver injury: inhibition of cytochrome P450 2E1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Selective Na+/H+ exchange inhibition by cariporide reduces liver fibrosis in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

The Ras antagonist, farnesylthiosalicylic acid (FTS), inhibits experimentally-induced liver cirrhosis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Gene transfer of the neuronal NO synthase isoform to cirrhotic rat liver ameliorates portal hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Prevention of rat hepatic fibrosis by the protease inhibitor, camostat mesilate, via reduced generation of active TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Adenoviral expression of a transforming growth factor-beta1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Communication between myocytes and fibroblasts in cardiac remodeling in angiotensin chimeric mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Halofuginone to prevent and treat thioacetamide-induced liver fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Hepatocyte growth factor induces collagenase (matrix metalloproteinase-1) via the transcription factor Ets-1 in human hepatic stellate cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Hepatocyte growth factor gene transfer into the liver via the portal vein using electroporation attenuates rat liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Relaxin inhibits effective collagen deposition by cultured hepatic stellate cells and decreases rat liver fibrosis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Fibrogenic and collagenolytic activity in carbon-tetrachloride-injured rats: beneficial effects of zinc administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Expression of the peripheral-type benzodiazepine receptor and apoptosis induction in hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Basal Expression of IκBα Is Controlled by the Mammalian Transcriptional Repressor RBP-J (CBF1) and Its Activator Notch1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Adenoviral-mediated transfer of p53 or retinoblastoma protein blocks cell proliferation and induces apoptosis in culture-activated hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

High efficiency gene transfer into cultured primary rat and human hepatic stellate cells using baculovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.5.423

21 January 2018

Identifiers

DOI

10.1517/14728222.8.5.423

1 reference

11 August 2017

1 reference

PubMed ID

15469393